| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.08 |